- Inhibition of the breast cancer by PPARγ agonist pioglitazone through…
Number of the records: 1  

Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway

  1. Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway / X. X. Jiao ... [et al.]. Neoplasma Vol. 67, no. 4 (2020), s. 834-842
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all